Zacks upgraded shares of Orthofix International NV (NASDAQ:OFIX) from a sell rating to a hold rating in a report issued on Wednesday.
According to Zacks, “Orthofix International N.V. is a leading provider of high-value, minimally invasive medical devices for the orthopaedic and trauma markets. Orthofix is well positioned to expand its focus and capitalise on the growing medical acceptance of high technology in orthopaedic treatment and spine repair. The company sells its diverse product line in different countries through its subsidiaries and distribution agreements with leading orthopaedic companies, including Sulzer Medica Group, Sofamor Danek Group, Kendall Healthcare Products and B. Braun. (PRESS RELEASE) “
In other Orthofix International NV news, Director Ronald A. Matricaria purchased 50,000 shares of Orthofix International NV stock in a transaction dated Tuesday, June 2nd. The stock was purchased at an average price of $32.65 per share, for a total transaction of $1,632,500.00. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.
Separately, analysts at TheStreet downgraded shares of Orthofix International NV from a buy rating to a hold rating in a research note on Monday, May 18th.
